REPORTS

Let’s Pullulate and Expand Your Business

Global Monoclonal antibodies (mAbs) Biosimilars Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jun 02, 2020  |  164 PAGES  |  REPORT CODE: CMM309054
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of quality, efficacy and safety to an innovative reference medicinal product.

The Monoclonal antibodies (mAbs) Biosimilars is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period. The research provides insights for the global Monoclonal antibodies (mAbs) Biosimilars market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Monoclonal antibodies (mAbs) Biosimilars industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Monoclonal antibodies (mAbs) Biosimilars Market Segmentations:

By Players:

  • Biocon

  • Celltrion

  • Hospira

  • 3SBio

  • Accord Healthcare

  • AET Biotech

  • Allergan

  • Amega Biotech

  • Others

By Types:

  • Erythropoietin (EPO)

  • Human Growth Hormone (HGH)

  • Granulocyte- Colony Stimulating Factor (G-CSF)

  • Monoclonal Antibody (mAb)

  • Insulin

  • Interferon (IFN)

  • Others

By End-User:

  • Anti-Cancer

  • Anti-Inflammatory/Autoimmune

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Monoclonal antibodies (mAbs) Biosimilars Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Erythropoietin (EPO) from 2014 to 2026

    • 1.3.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Human Growth Hormone (HGH) from 2014 to 2026

    • 1.3.3 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF) from 2014 to 2026

    • 1.3.4 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Monoclonal Antibody (mAb) from 2014 to 2026

    • 1.3.5 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Insulin from 2014 to 2026

    • 1.3.6 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Interferon (IFN) from 2014 to 2026

    • 1.3.7 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Anti-Cancer from 2014 to 2026

    • 1.4.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Anti-Inflammatory/Autoimmune from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Monoclonal antibodies (mAbs) Biosimilars Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Monoclonal antibodies (mAbs) Biosimilars by Major Types

    • 3.4.1 Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Erythropoietin (EPO)

    • 3.4.2 Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Human Growth Hormone (HGH)

    • 3.4.3 Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF)

    • 3.4.4 Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Monoclonal Antibody (mAb)

    • 3.4.5 Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Insulin

    • 3.4.6 Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Interferon (IFN)

    • 3.4.7 Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Others

4 Segmentation of Monoclonal antibodies (mAbs) Biosimilars Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Monoclonal antibodies (mAbs) Biosimilars by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Monoclonal antibodies (mAbs) Biosimilars in Anti-Cancer

    • 4.4.2 Market Size and Growth Rate of Monoclonal antibodies (mAbs) Biosimilars in Anti-Inflammatory/Autoimmune

5 Market Analysis by Major Regions

  • 5.1 Global Monoclonal antibodies (mAbs) Biosimilars Production Analysis by Major Regions

  • 5.2 Global Monoclonal antibodies (mAbs) Biosimilars Consumption Analysis by Major Regions

  • 5.3 Global Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export Analysis

6 Product Commodity of Monoclonal antibodies (mAbs) Biosimilars Market in Major Countries

  • 6.1 Top 5 Export Countries in Monoclonal antibodies (mAbs) Biosimilars market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Monoclonal antibodies (mAbs) Biosimilars market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Monoclonal antibodies (mAbs) Biosimilars market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Monoclonal antibodies (mAbs) Biosimilars market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Monoclonal antibodies (mAbs) Biosimilars market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Monoclonal antibodies (mAbs) Biosimilars market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis

  • 7.1 North America Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major Types

  • 7.2 North America Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major End-Users

  • 7.3 North America Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major Countries

    • 7.3.1 United States Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 7.3.2 Canada Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 7.3.3 Mexico Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

8 Europe Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis

  • 8.1 Europe Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major Types

  • 8.2 Europe Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major End-Users

  • 8.3 Europe Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major Countries

    • 8.3.1 Germany Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 8.3.2 UK Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 8.3.3 France Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 8.3.4 Italy Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 8.3.6 Spain Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 8.3.7 Belgium Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 8.3.8 Poland Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 8.3.9 Russia Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 8.3.10 Turkey Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

9 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis

  • 9.1 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major Types

  • 9.2 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major Countries

    • 9.3.1 China Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 9.3.2 Japan Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 9.3.4 India Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 9.3.6 South Korea Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

10 Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 10.3.2 Brazil Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 10.3.3 Nigeria Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

    • 10.3.4 South Africa Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate 

    • 10.3.5 Argentina Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Biocon

    • 11.1.1 Biocon Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Celltrion

    • 11.2.1 Celltrion Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Hospira

    • 11.3.1 Hospira Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 3SBio

    • 11.4.1 3SBio Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Accord Healthcare

    • 11.5.1 Accord Healthcare Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 AET Biotech

    • 11.6.1 AET Biotech Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Allergan

    • 11.7.1 Allergan Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Amega Biotech

    • 11.8.1 Amega Biotech Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Others

    • 11.9.1 Others Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 78 Figures and 142 Tables)

  • Figure Product Picture

  • Figure Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Erythropoietin (EPO) from 2014 to 2026

  • Figure Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Human Growth Hormone (HGH) from 2014 to 2026

  • Figure Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF) from 2014 to 2026

  • Figure Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Monoclonal Antibody (mAb) from 2014 to 2026

  • Figure Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Insulin from 2014 to 2026

  • Figure Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Interferon (IFN) from 2014 to 2026

  • Figure Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Anti-Cancer from 2014 to 2026

  • Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Anti-Inflammatory/Autoimmune from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Monoclonal antibodies (mAbs) Biosimilars Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Monoclonal antibodies (mAbs) Biosimilars

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Monoclonal antibodies (mAbs) Biosimilars by Different Types from 2014 to 2026

  • Table Consumption Share of Monoclonal antibodies (mAbs) Biosimilars by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Erythropoietin (EPO)

  • Figure Market Size and Growth Rate of Human Growth Hormone (HGH)

  • Figure Market Size and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF)

  • Figure Market Size and Growth Rate of Monoclonal Antibody (mAb)

  • Figure Market Size and Growth Rate of Insulin

  • Figure Market Size and Growth Rate of Interferon (IFN)

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Monoclonal antibodies (mAbs) Biosimilars by Different End-Users from 2014 to 2026

  • Table Consumption Share of Monoclonal antibodies (mAbs) Biosimilars by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Anti-Cancer

  • Figure Market Size and Growth Rate of Anti-Inflammatory/Autoimmune

  • Table Global Monoclonal antibodies (mAbs) Biosimilars Production by Major Regions

  • Table Global Monoclonal antibodies (mAbs) Biosimilars Production Share by Major Regions

  • Figure Global Monoclonal antibodies (mAbs) Biosimilars Production Share by Major Regions in 2014

  • Figure Global Monoclonal antibodies (mAbs) Biosimilars Production Share by Major Regions in 2018

  • Figure Global Monoclonal antibodies (mAbs) Biosimilars Production Share by Major Regions in 2026

  • Table Global Monoclonal antibodies (mAbs) Biosimilars Consumption by Major Regions

  • Table Global Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Regions

  • Figure Global Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Regions in 2014

  • Figure Global Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Regions in 2018

  • Figure Global Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Regions in 2026

  • Table North America Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export Analysis

  • Table Europe Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Monoclonal antibodies (mAbs) Biosimilars market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Monoclonal antibodies (mAbs) Biosimilars market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Monoclonal antibodies (mAbs) Biosimilars market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Monoclonal antibodies (mAbs) Biosimilars market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Monoclonal antibodies (mAbs) Biosimilars Consumption by Types from 2014 to 2026

  • Table North America Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types from 2014 to 2026

  • Figure North America Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2014

  • Figure North America Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2018

  • Figure North America Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2026

  • Table North America Monoclonal antibodies (mAbs) Biosimilars Consumption by End-Users from 2014 to 2026

  • Table North America Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users from 2014 to 2026

  • Figure North America Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2014

  • Figure North America Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2018

  • Figure North America Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2026

  • Table North America Monoclonal antibodies (mAbs) Biosimilars Consumption by Major Countries from 2014 to 2026

  • Table North America Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries in 2014

  • Figure North America Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries in 2018

  • Figure North America Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries in 2026

  • Figure United States Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Monoclonal antibodies (mAbs) Biosimilars Consumption by Types from 2014 to 2026

  • Table Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types from 2014 to 2026

  • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2014

  • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2018

  • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2026

  • Table Europe Monoclonal antibodies (mAbs) Biosimilars Consumption by End-Users from 2014 to 2026

  • Table Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2014

  • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2018

  • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2026

  • Table Europe Monoclonal antibodies (mAbs) Biosimilars Consumption by Major Countries from 2014 to 2026

  • Table Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries in 2014

  • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries in 2018

  • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries in 2026

  • Figure Germany Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure France Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption by Types from 2014 to 2026

  • Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2014

  • Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2018

  • Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2026

  • Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2014

  • Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2018

  • Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2026

  • Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries in 2026

  • Figure China Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandMonoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure India Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Major Countries in 2026

  • Figure GCC Countries Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Monoclonal antibodies (mAbs) Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Biocon

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

  • Figure Sales and Growth Rate Analysis of Biocon

  • Figure Revenue and Market Share Analysis of Biocon

  • Table Product and Service Introduction of Biocon

  • Table Company Profile and Development Status of Celltrion

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion

  • Figure Sales and Growth Rate Analysis of Celltrion

  • Figure Revenue and Market Share Analysis of Celltrion

  • Table Product and Service Introduction of Celltrion

  • Table Company Profile and Development Status of Hospira

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira

  • Figure Sales and Growth Rate Analysis of Hospira

  • Figure Revenue and Market Share Analysis of Hospira

  • Table Product and Service Introduction of Hospira

  • Table Company Profile and Development Status of 3SBio

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3SBio

  • Figure Sales and Growth Rate Analysis of 3SBio

  • Figure Revenue and Market Share Analysis of 3SBio

  • Table Product and Service Introduction of 3SBio

  • Table Company Profile and Development Status of Accord Healthcare

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Accord Healthcare

  • Figure Sales and Growth Rate Analysis of Accord Healthcare

  • Figure Revenue and Market Share Analysis of Accord Healthcare

  • Table Product and Service Introduction of Accord Healthcare

  • Table Company Profile and Development Status of AET Biotech

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AET Biotech

  • Figure Sales and Growth Rate Analysis of AET Biotech

  • Figure Revenue and Market Share Analysis of AET Biotech

  • Table Product and Service Introduction of AET Biotech

  • Table Company Profile and Development Status of Allergan

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

  • Figure Sales and Growth Rate Analysis of Allergan

  • Figure Revenue and Market Share Analysis of Allergan

  • Table Product and Service Introduction of Allergan

  • Table Company Profile and Development Status of Amega Biotech

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amega Biotech

  • Figure Sales and Growth Rate Analysis of Amega Biotech

  • Figure Revenue and Market Share Analysis of Amega Biotech

  • Table Product and Service Introduction of Amega Biotech

  • Table Company Profile and Development Status of Others

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Others

  • Figure Sales and Growth Rate Analysis of Others

  • Figure Revenue and Market Share Analysis of Others

  • Table Product and Service Introduction of Others


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top